Hydroxycarbamide
Indication
Treatment of essential thrombocythemia or polycythaemia vera with a high risk for thromboembolic complications
Red
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Immune system and Malignant Disease